Genmab A/S (GMAB)

NASDAQ: GMAB · IEX Real-Time Price · USD

28.56

-0.41 (-1.42%)

At close: Apr 23, 2024, 4:00 PM

28.64

+0.08 (0.28%)

Pre-market: Apr 24, 2024, 4:50 AM EDT

Genmab Cash Flow Statement

Financials in millions DKK. Fiscal year is January - December.

Millions DKK. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017
Net Income	5,452	2,957	4,758	2,166	1,472	1,104
Other Operating Activities	-1,540	-729	1,675	-840	-457	485
Operating Cash Flow	3,912	2,228	6,433	1,326	1,015	1,589
Operating Cash Flow Growth	75.58%	-65.37%	385.14%	30.64%	-36.12%	-
Capital Expenditures	-317	-252	-307	-111	-478	-89
Change in Investments	-2,444	-709	-2,044	-1,872	-1,300	-579
Investing Cash Flow	-2,761	-961	-2,351	-1,983	-1,778	-668
Share Issuance / Repurchase	-908	-447	0	3,873	-146	0
Debt Issued / Paid	-73	-58	-44	-31	0	0
Other Financing Activities	192	85	115	-182	75	215
Financing Cash Flow	-789	-420	71	3,660	-71	215
Exchange Rate Effect	574	850	-445	16	19	-95
Net Cash Flow	362	847	4,153	3,003	-834	1,136
Free Cash Flow	3,595	1,976	6,126	1,215	537	1,500
Free Cash Flow Growth	81.93%	-67.74%	404.20%	126.26%	-64.20%	-
Free Cash Flow Margin	24.78%	23.48%	60.59%	22.64%	17.75%	63.42%
Free Cash Flow Per Share	5.46	3.01	9.41	1.89	0.83	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).